Know Cancer

or
forgot password

Biospecimen Resource for Pancreas Research, a Data & Tissue Bank (Also Known as a Bio-repository, Bio-bank, Data & Tissue Database, Data & Tissue Registry, Etc.) to Help Advance Research in Pancreas Disease


N/A
18 Years
N/A
Open (Enrolling)
Both
Islet Cell Tumor, Pancreatic Cancer, Pancreatic Disease

Thank you

Trial Information

Biospecimen Resource for Pancreas Research, a Data & Tissue Bank (Also Known as a Bio-repository, Bio-bank, Data & Tissue Database, Data & Tissue Registry, Etc.) to Help Advance Research in Pancreas Disease


OBJECTIVES:

Primary

- To collect clinical data and family histories and blood and/or tissue samples from
patients diagnosed with pancreatic diseases, including pancreatic cancer, for use in
future studies.

- To collect information regarding food preparation and intake in these patients.

Secondary

- To make available to researchers medical data and biospecimens to enable them to
develop better ways to screen people at risk for pancreatic conditions, including
pancreatic cancer.

- To investigate genes or substances that increase susceptibility of developing
pancreatic conditions.

- To find agents that may help prevent, treat, or cure these conditions.

- To learn whether inherited factors increase the risk of pancreatic diseases, pancreatic
cancer, or other cancers.

OUTLINE: This is a multicenter study.

Patients complete two 1-hour surveys assessing health, clinical and family history of
pancreatic conditions including cancer, and food preparation and intake. Patients also
complete a 15- to 30-minute follow up survey at 6 months and 1 year to assess health, health
practices, and family history. A review of the patient's medical information is obtained
from the medical record.

Blood samples are collected for future research studies. Oral cells and stool samples may
also be collected for future studies.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Diagnosis or suspicion of at least one of the following:

- Pancreatic cancer

- Pancreatic mass

- Islet cell tumor

- Intraductal papillary mucinous neoplasms (IPMN)

- Hereditary pancreatitis

PATIENT CHARACTERISTICS:

- Able to understand and read English

- Mentally competent and able to provide informed consent

- Has not donated blood within the past 8 weeks

PRIOR CONCURRENT THERAPY:

- At least 7 days since prior blood transfusion

- At least 7 days since prior surgery

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

Collection of clinical data, health and family histories by survey

Outcome Time Frame:

baseline enrollment, 6 months, 12 months

Safety Issue:

No

Principal Investigator

Gloria M. Petersen, PhD, FACMG

Investigator Role:

Principal Investigator

Investigator Affiliation:

Mayo Clinic

Authority:

United States: Institutional Review Board

Study ID:

354-06

NCT ID:

NCT00830557

Start Date:

October 2000

Completion Date:

August 2014

Related Keywords:

  • Islet Cell Tumor
  • Pancreatic Cancer
  • Pancreatic Disease
  • recurrent pancreatic cancer
  • stage I pancreatic cancer
  • stage II pancreatic cancer
  • stage III pancreatic cancer
  • stage IV pancreatic cancer
  • recurrent islet cell carcinoma
  • pancreatic alpha cell carcinoma
  • pancreatic beta islet cell carcinoma
  • pancreatic delta cell carcinoma
  • pancreatic G-cell carcinoma
  • Pancreatic Diseases
  • Pancreatic Neoplasms
  • Adenoma, Islet Cell

Name

Location

Mayo Clinic Cancer CenterRochester, Minnesota  55905